Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration.
暂无分享,去创建一个
Robert F Mullins | Jian Huang | R. Mullins | Jessica M Skeie | J. M. Skeie | Micaela N Johnson | Elizabeth A Faidley | Jian Huang | Jessica M. Skeie | E. Faidley | Micaela N. Johnson
[1] A. Miettinen,et al. Ulex europaeus I lectin as a marker for tumors derived from endothelial cells. , 1983, American journal of clinical pathology.
[2] R. T. Smith,et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[3] P. D. de Jong,et al. Early stages of age-related macular degeneration: an immunofluorescence and electron microscopy study. , 1993, The British journal of ophthalmology.
[4] T KUWABARA,et al. Senile choroidal vascular patterns and drusen. , 1963, Archives of ophthalmology.
[5] J D Gass,et al. Drusen and disciform macular detachment and degeneration. , 1973, A M A Archives of Ophthalmology.
[6] B. Feigl. Age-related maculopathy – Linking aetiology and pathophysiological changes to the ischaemia hypothesis , 2008, Progress in Retinal and Eye Research.
[7] L. V. Johnson,et al. Accumulation of extracellular RGR-d in Bruch's membrane and close association with drusen at intercapillary regions. , 2009, Experimental eye research.
[8] N. Bressler,et al. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. 1994. , 2005, Retina.
[9] C. Curcio,et al. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. , 2003, The American journal of pathology.
[10] C. Reilly,et al. Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration. , 2006, Investigative ophthalmology & visual science.
[11] R. Mullins. Genetic Insights Into the Pathobiology of Age-related Macular Degeneration , 2007, International ophthalmology clinics.
[12] Jennifer I. Lim,et al. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.
[13] R. Klein,et al. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.
[14] H. Grossniklaus,et al. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. , 1999, Survey of ophthalmology.
[15] A. Ho,et al. Foveolar choroidal blood flow in age-related macular degeneration. , 1998, Investigative ophthalmology & visual science.
[16] K. Nakashima,et al. [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.
[17] R. Mullins,et al. Glycoconjugates of choroidal neovascular membranes in age-related macular degeneration. , 2005, Molecular vision.
[18] P. Raymond,et al. Improved method for obtaining 3-microns cryosections for immunocytochemistry. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[19] A C Bird,et al. Drusen as risk factors in age-related macular disease. , 1990, American journal of ophthalmology.
[20] Ching-Yu Cheng,et al. Pulsatile ocular blood flow in asymmetric exudative age related macular degeneration , 2001, The British journal of ophthalmology.
[21] J D Gottsch,et al. Oxidative damage and age-related macular degeneration. , 1999, Molecular vision.
[22] E. Stone. A very effective treatment for neovascular macular degeneration. , 2006, The New England journal of medicine.
[23] G. Lip,et al. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. , 2001, Ophthalmology.
[24] Takayuki Baba,et al. Relationship between RPE and choriocapillaris in age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.
[25] Marco A Zarbin,et al. PATHWAY-BASED THERAPIES FOR AGE-RELATED MACULAR DEGENERATION: An Integrated Survey of Emerging Treatment Alternatives , 2010, Retina.
[26] Masaru Miyagi,et al. Drusen proteome analysis: An approach to the etiology of age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[27] Christine A. Curcio,et al. Abundant Lipid and Protein Components of Drusen , 2010, PloS one.
[28] B. Godley,et al. Mitochondrial DNA damage and its potential role in retinal degeneration , 2008, Progress in Retinal and Eye Research.
[29] W. Green,et al. IRON TOXICITY AS A POTENTIAL FACTOR IN AMD , 2007, Retina.
[30] P T de Jong,et al. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. , 1994, Investigative ophthalmology & visual science.
[31] C. Curcio,et al. Basal linear deposit and large drusen are specific for early age-related maculopathy. , 1999, Archives of ophthalmology.
[32] S. Russell,et al. Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells. , 2010, Investigative ophthalmology & visual science.
[33] Alston Callahan,et al. The role of inflammation in the pathogenesis of age-related macular degeneration. , 2006, Survey of ophthalmology.
[34] H. Grossniklaus,et al. Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration. , 1996, Investigative ophthalmology & visual science.
[35] R. Mullins,et al. Macular and peripheral distribution of ICAM-1 in the human choriocapillaris and retina. , 2006, Molecular vision.
[36] S. Russell,et al. Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] E S Gragoudas,et al. Ocular blood flow velocity in age-related macular degeneration. , 1995, Ophthalmology.
[38] P. Penfold,et al. Senile macular degeneration: The involvement of immunocompetent cells , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[39] D. S. Mcleod,et al. Phosphatase enzyme histochemistry for studying vascular hierarchy, pathology, and endothelial cell dysfunction in retina and choroid , 2005, Vision Research.
[40] Sonia H Yoo,et al. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. , 2003, Survey of ophthalmology.
[41] Chi-Chao Chan,et al. Molecular pathology of age-related macular degeneration , 2009, Progress in Retinal and Eye Research.
[42] Johanna M Seddon,et al. The genetics of age-related macular degeneration: a review of progress to date. , 2006, Survey of ophthalmology.
[43] J L McRae,et al. Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease) , 2005, Journal of Medical Genetics.
[44] J. Matsubara,et al. Complement-associated deposits in the human retina. , 2008, Investigative ophthalmology & visual science.
[45] G. Ying,et al. Association of risk factors for choroidal neovascularization in age-related macular degeneration with decreased foveolar choroidal circulation. , 2010, American journal of ophthalmology.
[46] S. Sarks,et al. Ageing and degeneration in the macular region: a clinico-pathological study. , 1976, The British journal of ophthalmology.
[47] M. Killingsworth,et al. Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study , 1999, The British journal of ophthalmology.
[48] A. Bird,et al. Association of drusen deposition with choroidal intercapillary pillars in the aging human eye. , 2004, Investigative ophthalmology & visual science.
[49] A C Bird,et al. A fluorescein and indocyanine green angiographic study of choriocapillaris in age-related macular disease. , 1999, Archives of ophthalmology.
[50] Marco A Zarbin,et al. Current concepts in the pathogenesis of age-related macular degeneration. , 2004, Archives of ophthalmology.
[51] L. V. Johnson,et al. A potential role for immune complex pathogenesis in drusen formation. , 2000, Experimental eye research.
[52] Robert F Mullins,et al. A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.
[53] M L Bots,et al. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. , 1995, American journal of epidemiology.
[54] T. Hikichi,et al. Pulsatile ocular blood flow study: decreases in exudative age related macular degeneration , 2001, The British journal of ophthalmology.
[55] M. C. Leske,et al. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. , 2000, Archives of ophthalmology.
[56] T. Amemiya,et al. Natural Course of Experimental Choroidal Neovascularization: Three-Dimensional Study with Corrosion Cast and Scanning Electron Microscope , 2002, Ophthalmic Research.
[57] S. Vuk-Pavlović,et al. Immune cells in the human choroid , 2008, British Journal of Ophthalmology.
[58] M. Zarbin,et al. Age-Related Macular Degeneration: Review of Pathogenesis , 1998, European journal of ophthalmology.
[59] Magali Saint-Geniez,et al. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris , 2009, Proceedings of the National Academy of Sciences.